A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I study will determine the pharmacokinetic profile of patupilone in patients with
mild or moderately impaired hepatic function within 2 cycles of treatment. The study
population for this trial consists of patients with a documented advanced solid tumor.
Patients will be stratified into 3 groups: those with normal liver function, and those with
mild or moderate liver dysfunction.